drugset / Trial / NCT00740831

PGL4001 Versus GnRH-agonist in Uterine Myomas

NCT00740831

Phase 3 Completed 301 enrolled PregLem SA
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial will assess the efficacy and safety of PGL4001 versus GnRH agonist, over a 3-month period for the pre-operative treatment of pre-menopausal women suffering from excessive uterine bleeding due to uterine myoma.

Timeline

Start
2008-08
Primary completion
2010-01
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Leuprolide Other / unclassified 3.75 mg Intramuscular
Subject Ulipristal Acetate Unknown 5 mg Oral
Subject Ulipristal Acetate Unknown 10 mg Oral

Indications